CONMED Corporation (CNMD)
Return on total capital
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 118,079 | 171,907 | 181,271 | 200,326 | 198,014 | 162,607 | 142,918 | 120,604 | 69,322 | 63,270 | -51,701 | -41,956 | -3,645 | -2,309 | 110,951 | 108,589 | 95,985 | 99,694 | 52,652 | 45,653 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,008,260 | 1,002,870 | 977,636 | 962,681 | 932,896 | 881,832 | 854,664 | 834,222 | 796,205 | 780,194 | 752,453 | 745,545 | 716,337 | 672,968 | 789,546 | 785,435 | 755,683 | 744,499 | 725,570 | 709,038 |
| Return on total capital | 11.71% | 17.14% | 18.54% | 20.81% | 21.23% | 18.44% | 16.72% | 14.46% | 8.71% | 8.11% | -6.87% | -5.63% | -0.51% | -0.34% | 14.05% | 13.83% | 12.70% | 13.39% | 7.26% | 6.44% |
September 30, 2025 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $118,079K ÷ ($—K + $1,008,260K)
= 11.71%
Peer comparison
Sep 30, 2025
Company name
Symbol
Return on total capital
CONMED Corporation
CNMD
11.71%
Abbott Laboratories
ABT
17.01%
Stryker Corporation
SYK
20.07%